MedPath

Powered Handle Primary Sleeve Gastrectomy Study

Not Applicable
Recruiting
Conditions
Sleeve Gastrectomy
Interventions
Device: AEON Endoscopic Powered Stapler Handle and Reload
Registration Number
NCT06474637
Lead Sponsor
Lexington Medical Inc.
Brief Summary

The objective of this prospective, single arm, single-center study is to evaluate patients who are undergoing primary sleeve gastrectomy procedures and are surgically treated with the AEON Endoscopic Powered Handle Stapler and Stapler Reload. The primary endpoint is to assess the percentage of patients who encountered post-operative staple line complications (bleeding or leak), defined as requiring blood transfusion or revision surgery due to staple line complications.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  1. Be within the range of 18-65 years of age
  2. Patients undergoing primary sleeve gastrectomy procedures
  3. Psychosocially, mentally, and physically able to comply with protocol, post-operative management and follow-up schedule.
Exclusion Criteria
  1. Prior bariatric surgery procedure
  2. Sleeve gastrectomy procedure that is planned to be performed via open approach
  3. Patients receiving anticoagulant medication(s)
  4. Severe heart disease or lung problems
  5. Known sensitivity to implant materials
  6. Evidence of active (systemic or localized) infection at time of surgery
  7. Women who are pregnant or planning to get pregnant in the next 12 months
  8. Recent history of known alcohol and/or narcotic abuse
  9. Investigational drug or device use within 30 days
  10. Any other factors that may contribute, based on professional judgement of the treating surgeon, to the subject being a poor candidate for the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Single ArmAEON Endoscopic Powered Stapler Handle and Reload-
Primary Outcome Measures
NameTimeMethod
Post Operative Staple Line Complications1 week

The primary measure of effectiveness and safety will be determined by the incidence of post-operative staple line complications defined as requiring blood transfusion and revision surgery to treat staple line complications.

Secondary Outcome Measures
NameTimeMethod
36-Item Short Form Health Survey (SF-36)3 weeks

SF-36 scores will be collected at baseline and at the 3-week follow up appointment and compared for quality-of-life changes.

Hospital Stay1 week

Average hospital stay will be measure and compared in patients without post-operative staple line complications vs. patients with post-operative staple line complications.

Trial Locations

Locations (1)

Gijos Clinic

🇱🇹

Kaunas, Lithuania

© Copyright 2025. All Rights Reserved by MedPath